Meropenem Dosing in Acute Kidney Injury
In AKI with rapidly rising creatinine, assume GFR is very low (<10 mL/min) and start with half the standard dose (500 mg) every 24 hours, then reassess daily as kidney function evolves—do not rely on eGFR calculations since patients are not in steady state. 1
Core Principle: Trajectory-Based Dosing
In AKI, serum creatinine lags behind actual GFR changes by 24-48 hours. When creatinine is rising briskly or you only have a single initial value, the true GFR is lower than any calculated eGFR suggests. You must dose based on the presumed trajectory, not the snapshot.
Initial Dosing Strategy
For rising creatinine (presumed GFR <10 mL/min):
- Start with 500 mg every 24 hours (half the standard dose for severe renal impairment) 1
- If treating P. aeruginosa or severe infection: Consider 1 gram every 24 hours initially, then adjust based on clinical response and creatinine trajectory 1
- Administer as 3-hour infusion to optimize time above MIC 2, 3
Loading dose consideration:
- Give a full loading dose (1 gram) regardless of renal function to rapidly achieve therapeutic concentrations 4
- This is critical because volume of distribution is often increased in critically ill patients with AKI 5
Daily Reassessment Algorithm
Day 1-2: Creatinine still rising
- Continue conservative dosing (500 mg q24h or 1g q24h for severe infections)
- Monitor for clinical response
Day 3+: Creatinine plateauing or improving
- If creatinine stabilizing at CrCl 10-25 mL/min: Continue 500 mg q12h 1
- If creatinine improving to CrCl 26-50 mL/min: Increase to full dose q12h (500 mg for cSSSI, 1g for intra-abdominal) 1
- If creatinine improving to CrCl >50 mL/min: Return to standard q8h dosing 1
Prolonged Infusion Adjustments
Extended infusions still require renal dose adjustment—this is a critical pitfall. 4 Many clinicians mistakenly believe prolonged infusion eliminates the need for dose reduction in renal impairment.
For 3-hour infusions in AKI:
- CrCl <10 mL/min: 500 mg q24h (3-hour infusion) 2
- CrCl 10-25 mL/min: 500 mg q12h (3-hour infusion) 2
- CrCl 26-50 mL/min: 500 mg q8h or 1g q12h (3-hour infusion) 2
The 3-hour infusion optimizes the percentage of time above MIC (100% fT>MIC) but does not compensate for reduced clearance—you must still reduce total daily dose 2, 3.
Continuous Renal Replacement Therapy (CRRT)
If patient is on CRRT, dosing changes dramatically:
- CRRT increases meropenem clearance by 2.1-fold compared to non-CRRT AKI patients 6
- Recommended regimen: 500 mg q6h (3-hour infusion) 6, 2
- Alternative: 1 gram q8h (3-hour infusion) achieves 100% fT>MIC for MIC ≤4 mg/L 2, 3
- CRRT removes approximately 47% of the dose 7
For aggressive PK/PD targets (100% fT>4×MIC):
- Standard intermittent dosing fails to achieve this in CRRT 3
- Consider continuous infusion 3 grams/24 hours for MIC 1-2 mg/L pathogens 3
Intermittent Hemodialysis (IHD)
The FDA label states "inadequate information" for hemodialysis dosing 1, but recent evidence provides guidance:
For prolonged intermittent RRT (PIRRT):
- Alternate-day HD: 1000 mg loading dose, then 500 mg q8h (most session durations) 8
- Daily HD: 750 mg q8h for 4-8 hour sessions; 1000 mg q8h for 10-hour sessions 8
- Total daily doses of 2000-3000 mg are needed to maintain therapeutic levels 8
Critical Pitfalls to Avoid
Do not use Cockcroft-Gault in rising creatinine: The formula assumes steady state, which does not exist in evolving AKI 1
Do not underdose initially: Critically ill AKI patients have increased volume of distribution (median 46 L vs. normal 12-18 L), requiring full loading doses 5
Do not assume prolonged infusion eliminates need for dose reduction: Extended infusions optimize PK/PD but do not increase drug elimination 4, 2
Do not forget to escalate doses as kidney function recovers: Reassess daily—patients can transition from q24h to q8h dosing within 3-5 days 5
Standard doses fail in non-CRRT AKI: Only 20-30% of patients achieve adequate PK/PD targets with unadjusted dosing 5
Practical Approach Summary
Day 1 (rising creatinine, unknown trajectory):
- Loading: 1 gram IV over 30 minutes
- Maintenance: 500 mg q24h (3-hour infusion)
Day 2-3 (reassess creatinine trend):
- Still rising → continue 500 mg q24h
- Plateauing → consider 500 mg q12h
- Improving → adjust per CrCl estimate
Day 4+ (stabilized or improving):
- Dose according to current estimated CrCl using FDA table 1
- Continue 3-hour infusions if feasible
If CRRT initiated:
This trajectory-based approach prioritizes patient safety by avoiding both underdosing (treatment failure, resistance) and overdosing (neurotoxicity risk when trough >45 mg/L) 2, 3.